116 related articles for article (PubMed ID: 34183497)
1. Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection.
Xiu W; Huang Y; Li Y; Yu M; Gong Y
Anticancer Drugs; 2022 Jan; 33(1):80-90. PubMed ID: 34183497
[TBL] [Abstract][Full Text] [Related]
2. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.
Hong JC; Boyer MJ; Spiegel DY; Williams CD; Tong BC; Shofer SL; Moravan MJ; Kelley MJ; Salama JK
J Natl Compr Canc Netw; 2019 Feb; 17(2):127-139. PubMed ID: 30787126
[No Abstract] [Full Text] [Related]
3. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
6. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.
Deviany PE; Ganti AK; Islam KMM
Oncology (Williston Park); 2021 Mar; 35(3):111-118. PubMed ID: 33818051
[TBL] [Abstract][Full Text] [Related]
8. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
Stinchcombe TE; Fan W; Schild SE; Vokes EE; Bogart J; Le QT; Thomas CR; Edelman MJ; Horn L; Komaki R; Cohen HJ; Kishor Ganti A; Pang H; Wang X
Cancer; 2019 Feb; 125(3):382-390. PubMed ID: 30343497
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901.
Morikawa N; Inoue A; Sugawara S; Maemondo M; Harada T; Harada M; Fujita Y; Katoh T; Yokouchi H; Watanabe H; Usui K; Suzuki T; Sakakibara-Konishi J; Nagai H; Kanbe M; Nukiwa T
Lung Cancer; 2017 Sep; 111():38-42. PubMed ID: 28838395
[TBL] [Abstract][Full Text] [Related]
10. Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus.
Zeng X; Zeng D; Cheng J; Xu C; Sun C; Long H; Zhu B
Med Sci Monit; 2020 Apr; 26():e921676. PubMed ID: 32305990
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
12. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
13. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
14. The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer.
Bahçeci A; Kötek Sedef A; Işik D
Anticancer Drugs; 2022 Jan; 33(1):e534-e540. PubMed ID: 34407045
[TBL] [Abstract][Full Text] [Related]
15. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
Wang NF; Tang HM; Liu FL; Hong QY
Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
[TBL] [Abstract][Full Text] [Related]
16. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
17. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
Zhang S; Li S; Cheng Y
Thorac Cancer; 2020 Dec; 11(12):3536-3546. PubMed ID: 33058504
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma.
Kuo YW; Jerng JS; Shih JY; Chen KY; Yu CJ; Yang PC
J Thorac Oncol; 2011 Feb; 6(2):378-83. PubMed ID: 21173715
[TBL] [Abstract][Full Text] [Related]
20. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
